ENTITY
Genesis Molecular AI
Genesis Molecular AI
PulseAugur coverage of Genesis Molecular AI — every cluster mentioning Genesis Molecular AI across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-05-20 funding Genesis Molecular AI secured a $120 million deal with Incyte, including upfront cash and equity, to advance AI-driven drug discovery. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Genesis Molecular AI develops PEARL model for drug discovery
Genesis Molecular AI, a company focused on AI for drug discovery, has developed a new model called PEARL that can predict 3D protein structures with high accuracy. This breakthrough addresses the long-standing challenge…
-
Genesis AI partners with Incyte in $120M drug discovery deal
Genesis Molecular AI has secured a significant partnership with Incyte, a global biotech company, valued at $120 million. This deal includes $80 million in upfront cash and a $40 million equity investment, with potentia…